Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167821 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Irene García-Jiménez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Immunologia Translacional, Departament de Biologia Cellular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona (UB), Parc Cien…. Hauptthemen laut MEDLINE: L-Lactate Dehydrogenase, Dermatitis, Atopic, Cytokines, Pyroglyphidae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Economía y Competitividad e Instituto de Salud Carlos III, University of Barcelona, Agency for Management of University and Research Grants of the Generalitat de Catalunya.
Abstract (Originalsprache)
Lactate dehydrogenase (LDH) is a serum biomarker well known to correlate with disease severity in atopic dermatitis (AD). The aim of this study was to explore the cutaneous immune responses and the clinical profile of AD patients in relation to serum LDH levels. To this end, 47 untreated, adult patients with moderate-to-severe AD were stratified by median levels of serum LDH. Circulating memory T-cell responses to house dust mite (HDM) extract, in the presence of autologous lesional epidermal cells, were compared between AD subgroups. The LDHhigh group exhibited significantly higher IL-13, IL-5 and IL-9 in vitro responses confined to the cutaneous lymphocyte-associated antigen (CLA)+ subset compared to LDHlow patients. Clinically, LDHhigh patients were younger and exhibited more severe disease, elevated eosinophil counts in their blood, increased total and specific IgE levels in their plasma, and a higher prevalence of allergic rhinitis. Our data suggests that high LDH levels identify a subgroup of AD patients with a specific immune and clinical profile, and highlight the potential of LDH as a clinical parameter that may enable patient stratification for treatment selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunologia Translacional, Departament de Biologia Cellular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona (UB), Parc Científic de Barcelona (PCB), 08028 Barcelona, Spain.
- Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), 08028 Barcelona, Spain.
- Departament de Dermatologia, Hospital de Bellvitge, Universitat de Barcelona (UB), 08907 L'Hospitalet de Llobregat, Spain.
- Departament de Dermatologia, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), 08003 Barcelona, Spain.
- Departament de Dermatologia, Hospital General de Granollers, 08402 Granollers, Spain.
ORCID-Profile: Laia Curto-Barredo, Marta Bertolín-Colilla, Montserrat Bonfill-Ortí, Ramon M Pujol, Luis F Santamaria-Babí
Förderung
- Ministerio de Economía y Competitividad e Instituto de Salud Carlos III
- University of Barcelona
- Agency for Management of University and Research Grants of the Generalitat de Catalunya
- FIS/ISCIII (Ministerio de Economía y Competitividad e Instituto de Salud Carlos III)
- Fondo Europeo de Desarrollo Regional (FEDER)
Zitieren
APA
García-Jiménez, I., Figueras-Nart, I., Sans-de San Nicolás, L., Curto-Barredo, L., Bertolín-Colilla, M., Bonfill-Ortí, M., Díez-Ribas, S., Llobet-Del Pino, A., Guilabert-Vidal, A., Ryzhkova, A., Ferran, M., Pujol, R. M., & Santamaria-Babí, L. F. (2025). Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167821
Vancouver
García-Jiménez I, Figueras-Nart I, Sans-de San Nicolás L, Curto-Barredo L, Bertolín-Colilla M, Bonfill-Ortí M, et al. Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167821
BibTeX
@article{GarcaJimnez2025,
author = {García-Jiménez, Irene and Figueras-Nart, Ignasi and Sans-de San Nicolás, Lídia and Curto-Barredo, Laia and Bertolín-Colilla, Marta and Bonfill-Ortí, Montserrat and Díez-Ribas, Sandra and Llobet-Del Pino, Alex and Guilabert-Vidal, Antonio and Ryzhkova, Anna and Ferran, Marta and Pujol, Ramon M and Santamaria-Babí, Luis F},
title = {Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167821}
}
EUVIMED